SYDNEY Australia March 07 2019 GLOBE NEWSWIRE Immutep Limited ASX IMM; NASDAQ IMMP Immutep or the Company a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases today announced positive results from its prec...
↧